Does low intracellular magnesium raise neuromuscular excitability and contribute to cramps, restless legs, or arrhythmias?

Magnesium is a critical regulator of cellular electrical activity, with approximately 99% of total body stores located within cells. Because intracellular magnesium ($Mg^{2+}_i$) is the biologically active fraction for many enzymatic processes, its depletion can significantly alter cellular physiology even when serum levels appear normal.

Mechanistic explanations

The relationship between low intracellular magnesium and neuromuscular hyperexcitability is well-established through several distinct pathways:

• Ion Channel Regulation: Magnesium acts as a natural antagonist to calcium ($Ca^{2+}$) at the presynaptic terminal. When $Mg^{2+}_i$ is low, $Ca^{2+}$ influx through voltage-gated channels increases, triggering excessive release of acetylcholine (ACh) at the neuromuscular junction. This directly enhances synaptic gain and muscle irritability.
• Membrane Stabilization: Magnesium exerts a voltage-dependent block on sodium ($Na^+$) and calcium channels, as well as nicotinic acetylcholine receptors. Depletion removes these inhibitory blocks, lowering the depolarization threshold and making it easier for neurons and muscle cells to fire action potentials.
• Energy and Ion Transport: Magnesium is an essential cofactor for $Na^+/K^+$-ATPase. Deficiency impairs this pump’s ability to maintain ionic gradients, leading to altered resting membrane potentials and a higher propensity for spontaneous firing.

Clinical evidence

While the physiological mechanisms are robust, the clinical manifestation of these symptoms varies by condition:

• Muscle Cramps: Despite the mechanistic link, systematic reviews (including Cochrane) have found that magnesium supplementation often fails to provide meaningful relief for idiopathic muscle cramps in older adults. Benefit is more frequently observed in specific populations, such as those with pregnancy-associated cramps or patients undergoing hemodialysis.
• Restless Legs Syndrome (RLS): Evidence is more favorable for RLS. Limited trials indicate that magnesium, particularly when combined with vitamin B6, can reduce symptom severity and improve sleep quality, though it remains an adjunctive rather than a primary treatment.
• Cardiac Arrhythmias: There is a strong clinical correlation between low magnesium and arrhythmias such as atrial fibrillation and Torsade de pointes. Experimental cardiomyocyte models confirm that replenishing cytosolic magnesium stabilizes the membrane potential and reduces the risk of ectopy.

Practical considerations

A primary challenge in clinical practice is that standard serum magnesium tests often do not accurately reflect intracellular status. Red blood cell (RBC) magnesium is considered a more sensitive marker for long-term magnesium stores. For individuals experiencing the aforementioned symptoms, assessing RBC magnesium may provide a more accurate picture of magnesium's contribution to their clinical presentation.

Bottom line

Low intracellular magnesium increases neuromuscular excitability by removing inhibitory blocks on ion channels and enhancing neurotransmitter release. While the link to cardiac arrhythmias and RLS is well-supported mechanistically and clinically, the evidence for treating common muscle cramps with magnesium is less consistent in the general population.